J. Hussong et al., P53 PROTEIN OVEREXPRESSION IN INFILTRATING DUCTAL CARCINOMA OF FEMALEBREAST AND ITS ASSOCIATION WITH LYMPH-NODE METASTASIS, Oncology Reports, 4(5), 1997, pp. 917-920
Traditionally, prognosis in carcinoma of the breast is evaluated based
on size and differentiation of the tumor and status of lymph node met
astasis. In addition to these established markers, in this molecular a
ge other parameters such as overexpression of p53, c-erbB-2 and c-myc
proteins are increasingly used to assess the prognosis. At present, th
e prognostic value of the molecular markers, at best, is controversial
and conflicting. In this study, we examined 67 infiltrating ductal. c
arcinomas of female breast with and without lymph node metastasis for
p53 protein overexpression by immunohistochemistry on formalin-fixed,
paraffin-embedded tissue sections to ascertain if p53 positive tumors
have greater metastatic potential than p53 negative tumors. In additio
n, p53 overexpression was also correlated with tumor size, grade, expr
ession of estrogen and progesterone receptors, and age of the patient
to clarify the issue of relevance of p53 overexpression in prognostica
tion, p53 overexpression was observed in 39% of tumors and showed stro
ng correlation only with the histological grade of the tumor. The inci
dence of p53 overexpression in grade 1, grade 2 and grade 3 tumors was
0%, 33% and 58% respectively. Lymph node metastasis was less frequent
in tumors that overexpressed p53 protein. Twenty-seven percent of pri
mary tumors with lymph node metastasis showed p53 protein overexpressi
on, in contrast to 44% of tumors without metastasis. No correlation wa
s observed between p53 overexpression and all the other parameters eva
luated except progesterone receptor negative status. These results sug
gest that p53 overexpression is not an independent prognostic indicato
r and should not be used to predict lymph node metastasis or aggressiv
e behavior of the tumor.